Mallinckrodt Provides a Regulatory Update on Terlipressin
/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has...
Source: prnewswire.com
Stay updated with breaking news from Accessj Clin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has...
/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has...
DUBLIN, Feb. 22, 2022 /PRNewswire/ -- Mallinckrodt plc , a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter ... | February 22, 2022